Regarding that idea, a letter writer in The Wall Street Journal‘s Tuesday Letters section offered this after suggesting that Newsom’s effort would have the salutary outcome of demonstrating the foolishness of such a move:

Targeted subsidies for at-risk populations cost a fraction of the investment needed to bring “affordable” medications to the people….

That’s true enough, could Government actually do that and, further, keep it limited to the truly at-risk. However, actual competition in the market is free, and that brings down costs for everyone. Additionally, that competition allows far better and more accurate identification of those remaining few at-risk who still can’t afford their meds and would be legitimate targets of largesse. That also would facilitate more effective use of sources of largesse, beginning in order with family and friends first, followed by church and local charity, local community, county, then state governments, with the Feds last on the list, rather than the default source.